Morphine (Oral)
Brand names: Oramorph (oral solution), Sevredol (immediate-release tablet), MST Continus (modified-release), MXL (modified-release)
Oral morphine is a strong opioid analgesic available in immediate-release and modified-release oral preparations, used for moderate-to-severe acute pain and as the opioid of choice for chronic cancer pain and palliative care.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a full agonist at mu-opioid receptors in the central nervous system and periphery, reducing the perception of and emotional response to pain and depressing the brainstem respiratory centre.
Prescribing in practice
- Respiratory depression is the most serious risk and is potentiated by other CNS depressants such as benzodiazepines, gabapentinoids and alcohol, so co-prescribe with caution.
- Do not confuse or interchange immediate-release and modified-release preparations, and reduce doses in renal impairment and the elderly because the active metabolite accumulates.
- Anticipate and treat constipation, nausea and sedation, and counsel on the risks of tolerance and dependence with prolonged use.
Monitoring
Monitor pain control, sedation level, respiratory rate and bowel function, reviewing the dose regularly and tapering rather than stopping abruptly after prolonged use.
Counselling the patient
- This medicine can cause drowsiness, so do not drive or operate machinery until you know how it affects you.
- Take a regular laxative, as constipation is very common.
- Do not drink alcohol, and never take more than prescribed.
Evidence & guidelines
Oral morphine is recommended as a first-line strong opioid for cancer pain in NICE and WHO analgesic ladder guidance.
Reference: NICE NG31 (Cancer Pain); WHO Analgesic Ladder; Palliative Care Formulary (PCF6); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Modified Mallampati Classification · Airway Assessment
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Modified Early Warning Score (MEWS) · Early Warning
- Modified Shock Index (MSI) · Haemodynamic Assessment
- Modified Sgarbossa's Criteria (Smith Modification) for MI in LBBB · ECG Interpretation
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023